latest news stock values companies glp-1 obesity cardiometabolic Agonists Market Report 2025-2033, By Product, Molecule, and Geo Obesity GLP-1 Market
Description
As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based expert says the change likely wont bring immediate improvements for Prince Edward Islanders.
REM), high sensitivity c-reactive protein (0.27 [0.48, 0.07]
PlexusDx uses precision genetic testing to identify who benefits most from GLP-1 therapy and which compounds work best for your unique biology
Read the full article covered by Nutritional Outlook here:
The number of Americans taking a GLP-1 for weight management has increased nearly 600% over the past 6 years (FAIR Health, May 2025), making support products for those consumers more in-demand than ever
The warning dissuades PPL from using GLP-1 drugs &
